Across TCGA pan-cancer cohorts, RNU4ATAC16P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU4ATAC16P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNU4ATAC16P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU4ATAC16P is over-expressed in tumor.

BRCA, BLCA, and LUSC are the cancer types where RNU4ATAC16P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU4ATAC16P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.300	.016	4	view →
BLCA	Female	IV	+0.723	.008	3	view →
LUSC	Female	All	+0.302	.014	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU4ATAC16P RNA expression & survival · all RNU4ATAC16P data types